Questions About Cancer? 1-800-4-CANCER

All News Releases

Memorial Sloan-Kettering study compares survival for treatments of uncommon eye cancer
NCI Cancer Center News
(Posted: 06/18/2014) - In patients with advanced uveal melanoma, treatment with the agent selumetinib, compared with chemotherapy, resulted in an improved cancer progression-free survival time and tumor response rate, but no improvement in overall survival, according to a study in the June 18 issue of JAMA.

Duke scientists find that heparin derivative suppresses neuroblastoma tumor growth
NCI Cancer Center News
(Posted: 06/18/2014) - Researchers at Duke Medicine have identified a new strategy for treating neuroblastoma using a modified version of heparin, a century-old injectable drug that thins the blood to prevent clots from forming.

Duke researchers find that combining treatments boosts some smokers’ ability to quit
NCI Cancer Center News
(Posted: 06/18/2014) - Combining two smoking cessation therapies is more effective than using just one for male and highly nicotine-dependent smokers who weren't initially helped by the nicotine patch, according to researchers at Duke Medicine.

NIH and NSF collaborate to accelerate biomedical research innovations into the marketplace
NIH/NSF Press Release
(Posted: 06/18/2014) - A collaboration between the National Science Foundation and the National Institutes of Health will give NIH-funded researchers training to help them evaluate their scientific discoveries for commercial potential, with the aim of accelerating biomedical innovations into applied health technologies.

Lung-MAP Launches: First Precision Medicine Trial From National Clinical Trials Network
NCI Press Release
(Posted: 06/16/2014) - A unique public-private collaboration today announced the initiation of the Lung Cancer Master Protocol (Lung-MAP) trial, a multi-drug, multi-arm, biomarker-driven clinical trial for patients with advanced squamous cell lung cancer.
View the article in Spanish

Harvard and Broad Institute researchers chart cellular complexity of brain tumors
NCI Cancer Center News
(Posted: 06/13/2014) - By examining the gene expression patterns of many individual cells, one at a time, a research team was able to get a finer picture of the cellular composition of gliobastoma.

Georgetown U scientists find that tamoxifen-resistant breast cancer in mice can be reversed when drug paired with anti-malaria agent
NCI Cancer Center News
(Posted: 06/13/2014) - The inexpensive anti-malarial drug hydroxychloroquine reverses resistance to tamoxifen, a widely used breast cancer drug, in mice.

Huntsman researchers find that childhood cancer survivors are hospitalized frequently years after cancer treatment
NCI Cancer Center News
(Posted: 06/12/2014) - Survivors of childhood cancers were hospitalized more often and for longer durations because of blood disorders and other problems, many years after cancer treatment was completed, compared with the general population.
View the article in Spanish

Lombardi Cancer Center study suggests resistance to lung cancer targeted therapy can be reversed
NCI Cancer Center News
(Posted: 06/11/2014) - Scientists at Georgetown Lombardi Comprehensive Cancer Center and the National Cancer Institute have discovered why intrinsic resistance occurs to lung cancer targeted therapy -- and they pinpoint a drug they say could potentially reverse it.

Duke researchers find that lifetime cancer risk from heart imaging is low for most children, but rises with more complex tests
NCI Cancer Center News
(Posted: 06/10/2014) - Children with heart disease are exposed to low levels of radiation during X-rays, which do not significantly raise their lifetime cancer risk.

< Previous  21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41  Next >